Stay updated on VS-6766 and Everolimus Clinical Trial

Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VS-6766 and Everolimus Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history updated: added 'Revision: v3.4.3' and removed 'Revision: v3.4.2'.
    Difference
    0.0%
    Check dated 2026-03-12T02:27:18.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the earlier government funding/operating-status notices (v3.4.1) were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:30:53.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice was added at the top of the page stating potential delays and that the NIH Clinical Center is open. The recruitment status indicator 'Active, not recruiting' was removed, and the page includes a revision notice (Revision: v3.4.1) with updated dates in January 2026.
    Difference
    0.9%
    Check dated 2026-02-04T06:51:31.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and introduces QC-related labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T05:09:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - Revision label updated from v3.3.3 to v3.3.4. No user-facing content changes were detected.
    Difference
    0.0%
    Check dated 2026-01-14T02:17:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a new Locations section with Surrey; removed the Surrey Locations block and the HHS Vulnerability Disclosure link as part of revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:31:31.000Z thumbnail image

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.